KIRKLAND, QC — Merck (NYSE: MRK), known as MSD outside the United States is proud to announce that Chantal Desbiens, Executive Director, Legal and Compliance & Chief Privacy Officer at Merck… Read More
VICTORIA, BC — /CNW/ — Eupraxia Pharmaceuticals Inc. (“Eupraxia” or the “Company”) (TSX: EPRX), a Phase 2 clinical-stage biotechnology company with an innovative drug delivery technology platform, today announced that… Read More
MISSISSAUGA, ON — Roche Canada today announced the creation of the Advancing Inclusive Research® Site Alliance. This coalition of clinical research sites will partner with Roche to advance the representation of… Read More
VANCOUVER, BC — PharmAla Biotech Holdings Inc. (the “Company” or “PharmAla”) (CSE: MDMA) (OTC: PMBHF), a biotechnology company focused on the research, development and manufacturing MDXX class molecules (including MDMA),… Read More
Zigakibart treatment continues to demonstrate rapid and sustained reductions in mechanistic biomarkers, including IgA and Gd-IgA1 levels, which correspond to clinically meaningful proteinuria reductions in patients with IgAN across Cohorts… Read More
